Chinese english Germany Japanese Korea

(1R,5S)-N-Methoxycarbonyl-1,2,3,4,5,6-hexahydro-1,5-Methanopyrido-[1,2-a][1,5]diazocin-8-one (-)-2

(1R,5S)-N-Methoxycarbonyl-1,2,3,4,5,6-hexahydro-1,5-Methanopyrido-[1,2-a][1,5]diazocin-8-one (-)-2 Struktur
125109-97-9
CAS-Nr.
125109-97-9
Englisch Name:
(1R,5S)-N-Methoxycarbonyl-1,2,3,4,5,6-hexahydro-1,5-Methanopyrido-[1,2-a][1,5]diazocin-8-one (-)-2
Synonyma:
(1R,5S)-N-Methoxycarbonyl-1,2,3,4,5,6-hexahydro-1,5-Methanopyrido-[1,2-a][1,5]diazocin-8-one (-)-2;1,5-Methano-2H-pyrido[1,2-a][1,5]diazocine-3(4H)-carboxylic acid, 1,5,6,8-tetrahydro-8-oxo-, methyl ester, (1R,5R)-
CBNumber:
CB72735556
Summenformel:
C13H16N2O3
Molgewicht:
248.28
MOL-Datei:
125109-97-9.mol
Request For Quotation

(1R,5S)-N-Methoxycarbonyl-1,2,3,4,5,6-hexahydro-1,5-Methanopyrido-[1,2-a][1,5]diazocin-8-one (-)-2 Eigenschaften

Siedepunkt:
464.8±44.0 °C(Predicted)
Dichte
1.32±0.1 g/cm3(Predicted)
pka
-0.90±0.20(Predicted)

Sicherheit

(1R,5S)-N-Methoxycarbonyl-1,2,3,4,5,6-hexahydro-1,5-Methanopyrido-[1,2-a][1,5]diazocin-8-one (-)-2 Chemische Eigenschaften,Einsatz,Produktion Methoden

(1R,5S)-N-Methoxycarbonyl-1,2,3,4,5,6-hexahydro-1,5-Methanopyrido-[1,2-a][1,5]diazocin-8-one (-)-2 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(1R,5S)-N-Methoxycarbonyl-1,2,3,4,5,6-hexahydro-1,5-Methanopyrido-[1,2-a][1,5]diazocin-8-one (-)-2 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Acesys Pharmatech 18860950986
 tangmanman@zenjipharma.com China 1735 55
Nanjing Becas pharmatech Ltd. 13912903754
 info@becaspharma.com China 2257 58
Hangzhou Yaoruiyicheng Biological Medicine Co., Ltd 18072846723
 caigou1@witofly.com China 18926 58
  • (1R,5S)-N-Methoxycarbonyl-1,2,3,4,5,6-hexahydro-1,5-Methanopyrido-[1,2-a][1,5]diazocin-8-one (-)-2
  • 1,5-Methano-2H-pyrido[1,2-a][1,5]diazocine-3(4H)-carboxylic acid, 1,5,6,8-tetrahydro-8-oxo-, methyl ester, (1R,5R)-
  • 125109-97-9
Copyright 2019 © ChemicalBook. All rights reserved